[1]
U. Bacher, S. Brechbühl, B. . Jeker, and T. Pabst, “REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY: Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021012, Jan. 2021.